2-FDCK: What Is 2-Fluorodeschloroketamine? Uses, Effects, Risks & Research

What Is 2-FDCK?

2-FDCK is a synthetic new psychoactive substance (NPS) of the arylcyclohexylamine class. It goes by several other names including 2-Fluorodeschloroketamine, 2F-DCK. It is chemically related to the compound ketamine and has been investigated primarily in forensic, toxicological and pharmacological research.

According to the IUPAC name, 2-FDCK is 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one. According to the World Health Organisation, 2-FDCK has never been sold as a medicinal product, and has no known therapeutic use.

Ketamine and 2-FDCK

The chemical structure of 2-FDCK is similar to that of ketamine, except for the substitution of a fluorine in the parent compound. This structural relationship has led researchers to investigate whether its pharmacological and toxicological properties resemble those of ketamine.

However, 2-FDCK should not be regarded as a safe and interchangeable alternative to ketamine. Human data are still limited and due to differences in metabolism and pharmacological activity the effects may be unpredictable.

What Does 2-FDCK Do to the Body?

Research describes 2-FDCK as a dissociative. Reported clinical effects include impaired consciousness, agitation, abnormal behaviour, dizziness, hallucinations, changes in perception, hypertension, tachycardia and in serious cases convulsions or loss of consciousness.

Researchers and health professionals therefore consider 2-FDCK a substance of serious toxicological concern and not an established medicine.

Pharmacology and Research of 2-FDCK

There is very little scientific information available on 2FDCK. The metabolism and its relation to other ketamine-type compounds have been studied. Laboratory studies have identified several metabolites, including nor and other biotransformed compounds. However, the effects of THC in humans are not yet fully understood.

In addition, a case series of 20 confirmed exposures reported predominantly neurologic and cardiovascular effects. Many cases also involved other ketamine-type substances, making it difficult to identify the individual contribution of 2-FDCK.

Safety and Risk Issues

Possible health effects

Can have serious adverse effects. Problems reported include:

• Altered consciousness
• Confusion and weird behaviour
• Fantasies and excitement
• Dizziness and nausea.
• The heart races.
• Hypertension
• Seizures
• Unconsciousness
• Possible lethal intoxication

There have been reports of deaths and a case of severe self-injury associated with exposure to 2-FDCK in the published forensic literature.

Why Is It Difficult to Assess 2-FDCK?

One major problem is the limited amount of reliable human research available. Furthermore, new psychoactive substances may be present in products with unexpected compounds or mixtures. Therefore, the actual substance and its concentration may not always be the same as the label or description.

Recent surveillance research has also described serious health outcomes among people exposed to ketamine analogues, with this accounting for a large proportion of reported cases.

Legal/Regulatory Environment

The legal status of 2-FDCK differs between jurisdictions and may change over time. The WHO Expert Committee on Drug Dependence recommended that the international community control it under Schedule II of the 1971 Convention on Psychotropic Substances.

In the United States, federal authorities moved towards a temporary Schedule I placement in 2026 due to concerns about its abuse potential and public safety.

Thus, anyone conducting legitimate research should check the current laws, institutional requirements and applicable controlled-substance regulations in their jurisdiction.

Summary

2-FDCK is a synthetic dissociative new psychoactive substance related to ketamine. Although researchers have studied its chemistry, metabolism, and toxicology, evidence of its effects in humans remains limited. Serious neurological and cardiovascular effects have been reported and deaths have been documented in forensic reports.